" rel="stylesheet">
Skip Main Navigation
Page Content
This event has ended

CSO Leadership Series: Tony Coyle, CSO, Pfizer Centers for Therapeutic Innovation


Wednesday, October 15, 2014 from 8:30 AM to 10:00 AM (EDT)

CSO Leadership Series: Tony Coyle, CSO, Pfizer Centers...

Ticket Information

Ticket Type Sales End Price Fee Quantity
NewYorkBIO Fellows Program Member Ended $45.00 $3.47
NewYorkBIO Member Ended $65.00 $4.57
Future Member
Non-member registration is limited.
Ended $95.00 $6.22

Who's Going

Loading your connections...

Share CSO Leadership Series: Tony Coyle, CSO, Pfizer Centers for Therapeutic Innovation

Event Details

October 15, 2014




Anthony Coyle, PhD


Vice President and Chief Scientific Officer


Pfizer Centers for Therapeutic Innovation


Anthony “Tony” Coyle is Vice President and Chief Scientific Officer of the Centers for Therapeutic Innovation (CTI) based out of Boston. CTI was established in late 2010 as a new model to drive innovation in BioTherapeutics R & D. Tony is responsible for the CTI sites, which currently include CTI – New York City, CTI- Boston and CTI-California. Tony is supported by his leadership team, which includes the site heads of each CTI, his operations team and project management.


As a former Vice President and Global Head of Respiratory, Inflammation, and Autoimmunity Research at Medimmune Biologics, a Division of AstraZeneca, Tony has advanced a biologic portfolio from discovery to Phase Two in the areas of Respiratory and Autoimmune diseases including Lupus, Asthma and COPD. Prior to joining Medimmune, Tony was Director of Research at Millennium Pharmaceuticals, where he led a group responsible for the identification of novel target genes as well as for late stage lead optimization and delivery of both small molecule and biologic development candidates.


About the CSO Leadership Series

Chief Science Officers and Chief Medical Officers have a tough job—organizing and managing R&D uncovering new disruptive discovery and development models; assessing the impact of pricing, reimbursement, and regulation—all while raising capital, working with investors, and strategizing appropriate exits.

NewYorkBIO’s CSO Leadership Series is designed to help bioscience CSO/CMOs to engage with experienced industry leaders and address the unique challenges associated with the job. Attendees will gain guidance on strategic planning, exit planning, and insight into the trends affecting the future of medical research in the emerging life science space

Limited to 25 attendees, the CSO Leadership Series is restricted to life science executives (no service providers beyond the sponsor) and will offer a unique opportunity to hear directly from—and to network with—New York’s life science leadership.


Exclusive CEO Leadership Series Sponsor






George Yancopoulos, MD, PhD

Founding Scientist, President, Regeneron Laboratories

Chief Scientific Officer, Regeneron

George D. Yancopoulos, M.D., Ph.D., joined  Regeneron in 1989 as its Founding Scientist and is currently President, Regeneron Laboratories and Chief Scientific Officer. He received his M.D. and Ph.D. from Columbia University. Dr. Yancopoulos was the 11th most highly cited scientist in the world in the 1990s, and in 2004 he was elected to be a member of the National Academy of Sciences. Dr. Yancopoulos, together with key members of his team, is a principal inventor and developer of Regeneron's three FDA-approved drugs - including EYLEA® (aflibercept) Injection, ZALTRAP® (ziv-aflibercept) Injection for Intravenous Infusion, and ARCALYST® (rilonacept) Injection - as well as of its foundation technologies including the TRAP technology, VelociGene®, and VelocImmune®.


More to come!

Have questions about CSO Leadership Series: Tony Coyle, CSO, Pfizer Centers for Therapeutic Innovation? Contact NewYorkBIO

When & Where

Offices of Moses & Singer
Chrysler Building
405 Lexington Ave
New York, NY 10174

Wednesday, October 15, 2014 from 8:30 AM to 10:00 AM (EDT)

  Add to my calendar



NewYorkBIO is the life science trade association of New York, dedicated to the development and growth of New York State-based bioscience-related industries and institutions, and to strengthening the competitiveness of New York State as a premier global location for biotechnology/biomedical research, education and industry.

Through our membership of over 200 bioscience companies, world class research institutes, and related professional services biotechnology professionals are able to access the information, resources and assistance they need to make their ventures a success.

  Contact the Organizer
CSO Leadership Series: Tony Coyle, CSO, Pfizer Centers for Therapeutic Innovation
New York, NY Events Networking Business

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.